vs
Side-by-side financial comparison of CALLAN JMB INC. (CJMB) and Lucid Diagnostics Inc. (LUCD). Click either name above to swap in a different company.
Lucid Diagnostics Inc. is the larger business by last-quarter revenue ($1.2M vs $1.2M, roughly 1.0× CALLAN JMB INC.). CALLAN JMB INC. runs the higher net margin — -223.8% vs -858.5%, a 634.8% gap on every dollar of revenue.
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.
CJMB vs LUCD — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2M | $1.2M |
| Net Profit | $-2.6M | $-10.4M |
| Gross Margin | 30.3% | — |
| Operating Margin | -216.6% | -971.0% |
| Net Margin | -223.8% | -858.5% |
| Revenue YoY | — | 3.3% |
| Net Profit YoY | — | 16.0% |
| EPS (diluted) | $-0.58 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.2M | — | ||
| Q3 25 | $1.4M | $1.2M | ||
| Q2 25 | $1.7M | $1.2M | ||
| Q1 25 | $1.4M | $828.0K | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | — | $1.2M | ||
| Q2 24 | — | $976.0K | ||
| Q1 24 | — | $1.0M |
| Q4 25 | $-2.6M | — | ||
| Q3 25 | $-2.7M | $-10.4M | ||
| Q2 25 | $-1.4M | $-4.4M | ||
| Q1 25 | $-1.2M | $-26.9M | ||
| Q4 24 | — | $-11.5M | ||
| Q3 24 | — | $-12.4M | ||
| Q2 24 | — | $-11.0M | ||
| Q1 24 | — | $-10.6M |
| Q4 25 | 30.3% | — | ||
| Q3 25 | 34.1% | — | ||
| Q2 25 | 38.6% | — | ||
| Q1 25 | 42.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -216.6% | — | ||
| Q3 25 | -129.9% | -971.0% | ||
| Q2 25 | -84.2% | -978.8% | ||
| Q1 25 | -85.4% | -1508.1% | ||
| Q4 24 | — | -1033.8% | ||
| Q3 24 | — | -997.8% | ||
| Q2 24 | — | -1146.7% | ||
| Q1 24 | — | -1078.1% |
| Q4 25 | -223.8% | — | ||
| Q3 25 | -188.8% | -858.5% | ||
| Q2 25 | -83.9% | -381.7% | ||
| Q1 25 | -85.6% | -3249.8% | ||
| Q4 24 | — | -964.2% | ||
| Q3 24 | — | -1055.5% | ||
| Q2 24 | — | -1127.6% | ||
| Q1 24 | — | -1060.1% |
| Q4 25 | $-0.58 | — | ||
| Q3 25 | $-0.61 | $-0.10 | ||
| Q2 25 | $-0.31 | $-0.08 | ||
| Q1 25 | $-0.32 | $-0.52 | ||
| Q4 24 | — | $-0.17 | ||
| Q3 24 | — | $-0.25 | ||
| Q2 24 | — | $-0.23 | ||
| Q1 24 | — | $-0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.1M | $47.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.3M | $25.8M |
| Total Assets | $5.8M | $53.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.1M | — | ||
| Q3 25 | $2.8M | $47.3M | ||
| Q2 25 | $4.2M | $31.1M | ||
| Q1 25 | $5.2M | $25.2M | ||
| Q4 24 | — | $22.4M | ||
| Q3 24 | — | $14.5M | ||
| Q2 24 | — | $24.9M | ||
| Q1 24 | — | $24.8M |
| Q4 25 | $2.3M | — | ||
| Q3 25 | $4.2M | $25.8M | ||
| Q2 25 | $5.8M | $7.9M | ||
| Q1 25 | $6.8M | $-5.4M | ||
| Q4 24 | — | $5.4M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $16.0M | ||
| Q1 24 | — | $11.9M |
| Q4 25 | $5.8M | — | ||
| Q3 25 | $7.7M | $53.2M | ||
| Q2 25 | $9.0M | $38.7M | ||
| Q1 25 | $8.5M | $32.8M | ||
| Q4 24 | — | $30.7M | ||
| Q3 24 | — | $22.6M | ||
| Q2 24 | — | $34.1M | ||
| Q1 24 | — | $32.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-659.0K | $-10.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-659.0K | — | ||
| Q3 25 | $-1.8M | $-10.9M | ||
| Q2 25 | $-563.3K | $-10.5M | ||
| Q1 25 | $-1.6M | $-12.5M | ||
| Q4 24 | — | $-9.9M | ||
| Q3 24 | — | $-10.2M | ||
| Q2 24 | — | $-11.5M | ||
| Q1 24 | — | $-12.6M |
| Q4 25 | — | — | ||
| Q3 25 | $-1.9M | — | ||
| Q2 25 | $-995.8K | — | ||
| Q1 25 | $-1.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | -133.5% | — | ||
| Q2 25 | -59.8% | — | ||
| Q1 25 | -108.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 11.7% | — | ||
| Q2 25 | 26.0% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CJMB
| Governmental | $1.1M | 91% |
| Other | $106.5K | 9% |
LUCD
Segment breakdown not available.
